Has the CLOSURE-AF trial changed your threshold for referring a patient with atrial fibrillation for left atrial appendage closure?
Landmesser et al., PMID 41849741
1 Answer
Mednet MemberInvited Expert
Cardiology · Lankenau Heart Group
Answered on
The totality of data from recent clinical trials affirms that LAAO implantation should be viewed as a useful alternative strategy for patients at high risk of stroke and systemic embolism. Although closure can be used as a first-line treatment in select patients, I continue to recommend a trial of a...
Join for free or sign in to see the full answer